Galit Alter

Galit Alter is an immunologist and virologist, professor of medicine at Harvard Medical School, and group leader at the Ragon Institute of MGH, MIT and Harvard. She is known for her work on the expansion of particular natural killer cell subtypes in response to HIV-1 infection. She has also contributed to the understanding of how SARS-CoV-2 antibody titers correlate with sustained humoral protection, including identifying coordinated immune cell-antibody signatures that may predict COVID-19 infection outcome.

From October 2022 to October 2024 she joined Moderna on a sabbatical from the Ragon Institute to lead the immunology group within Infectious Disease Research. Provided by Wikipedia
Showing 1 - 17 results of 17 for search 'Galit Alter', query time: 0.06s Refine Results
  1. 1
    The immunological impact of revaccination in a hybrid-immune world

    The immunological impact of revaccination in a hybrid-immune world by Mary Bausch-Jurken, Galit Alter

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Marked heterogeneity in malaria infection rate in a Malian longitudinal cohort

    Marked heterogeneity in malaria infection rate in a Malian longitudinal cohort by Emily LaVerriere, Zachary M. Johnson, Meg Shieh, Nadege Nziza, Galit Alter, Caroline O. Buckee, Peter D. Crompton, Boubacar Traore, Tuan M. Tran, Daniel E. Neafsey

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    High‐resolution definition of humoral immune response correlates of effective immunity against HIV

    High‐resolution definition of humoral immune response correlates of effective immunity against HIV by Galit Alter, Karen G Dowell, Eric P Brown, Todd J Suscovich, Anastassia Mikhailova, Alison E Mahan, Bruce D Walker, Falk Nimmerjahn, Chris Bailey‐Kellogg, Margaret E Ackerman

    Published 2018-03-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    KIR polymorphisms modulate peptide-dependent binding to an MHC class I ligand with a Bw6 motif.

    KIR polymorphisms modulate peptide-dependent binding to an MHC class I ligand with a Bw6 motif. by Arnaud D Colantonio, Benjamin N Bimber, William J Neidermyer, R Keith Reeves, Galit Alter, Marcus Altfeld, R Paul Johnson, Mary Carrington, David H O'Connor, David T Evans

    Published 2011-03-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Anti-dengue virus antibodies that elicit complement-mediated lysis of Zika virion correlate with protection from severe dengue disease

    Anti-dengue virus antibodies that elicit complement-mediated lysis of Zika virion correlate with protection from severe dengue disease by Antonio G. Dias, Jr., Elias M. Duarte, Jose Victor Zambrana, Jaime A. Cardona-Ospina, Sandra Bos, Vicky Roy, Julia Huffaker, Guillermina Kuan, Angel Balmaseda, Galit Alter, Eva Harris

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Humoral correlates of protection against Mycobacterium tuberculosis following intravenous BCG vaccination in rhesus macaques

    Humoral correlates of protection against Mycobacterium tuberculosis following intravenous BCG vaccination in rhesus macaques by Edward B. Irvine, Patricia A. Darrah, Shu Wang, Chuangqi Wang, Ryan P. McNamara, Mario Roederer, Robert A. Seder, Douglas A. Lauffenburger, JoAnne L. Flynn, Sarah M. Fortune, Galit Alter

    Published 2024-12-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Divergent antibody recognition profiles are generated by protective mRNA vaccines against Marburg and Ravn viruses

    Divergent antibody recognition profiles are generated by protective mRNA vaccines against Marburg and Ravn viruses by Michelle Meyer, Bronwyn M. Gunn, Colette Pietzsch, Chandru Subramani, Kritika Kedarinath, Paula P. Villarreal, Matthew A. Hyde, Erica Ollmann Saphire, James E. Crowe, Galit Alter, Sunny Himansu, Andrea Carfi, Alexander Bukreyev

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Adenovectored RSV prefusion glycoprotein + soluble glycoprotein combination immunization establishes persistent opsonophagocytic antibody response through IgG3

    Adenovectored RSV prefusion glycoprotein + soluble glycoprotein combination immunization establishes persistent opsonophagocytic antibody response through IgG3 by Xin Tong, Ross Blanc, Deniz Cizmeci, Hadar Malca, Jaewon Kang, Christy Comeaux, Benoit Callendret, Arangassery Rosemary Bastian, Mehak Zahoor Khan, Galit Alter, Daniel Lingwood, Ryan P. McNamara, Ryan P. McNamara

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    HLA Alleles Associated with Delayed Progression to AIDS Contribute Strongly to the Initial CD8(+) T Cell Response against HIV-1.

    HLA Alleles Associated with Delayed Progression to AIDS Contribute Strongly to the Initial CD8(+) T Cell Response against HIV-1. by Marcus Altfeld, Elizabeth T Kalife, Ying Qi, Hendrik Streeck, Mathias Lichterfeld, Mary N Johnston, Nicole Burgett, Martha E Swartz, Amy Yang, Galit Alter, Xu G Yu, Angela Meier, Juergen K Rockstroh, Todd M Allen, Heiko Jessen, Eric S Rosenberg, Mary Carrington, Bruce D Walker

    Published 2006-10-01
    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    SARS-CoV-2 antibodies protect against reinfection for at least 6 months in a multicentre seroepidemiological workplace cohort.

    SARS-CoV-2 antibodies protect against reinfection for at least 6 months in a multicentre seroepidemiological workplace cohort. by Emilie Finch, Rachel Lowe, Stephanie Fischinger, Michael de St Aubin, Sameed M Siddiqui, Diana Dayal, Michael A Loesche, Justin Rhee, Samuel Beger, Yiyuan Hu, Matthew J Gluck, Benjamin Mormann, Mohammad A Hasdianda, Elon R Musk, Galit Alter, Anil S Menon, Eric J Nilles, Adam J Kucharski, CMMID COVID-19 working group and the SpaceX COVID-19 Cohort Collaborative

    Published 2022-02-01
    Get full text
    Article
    Save to List
    Saved in:
  11. 11
    Rhesus macaques show increased resistance to repeated SHIV intrarectal exposure following a heterologous regimen of rVSV vector vaccine expressing HIV antigen

    Rhesus macaques show increased resistance to repeated SHIV intrarectal exposure following a heterologous regimen of rVSV vector vaccine expressing HIV antigen by Joseph Jelinski, Monika M. Kowatsch, Marc-Alexandre Lafrance, Alice Berger, Jannie Pedersen, Hiva Azizi, Yue Li, Florine Scholte, Alejandro Gomez, Natasha Hollett, Toby Le, Matthew Wade, Hugues Fausther-Bovendo, Marc-Antoine de La Vega, George Babuadze, Ara, Claude Lamarre, Trina Racine, Chil-Yong Kang, Xiao-Jian Yao, Galit Alter, Eric Arts, Keith R. Fowke, Gary P. Kobinger

    Published 2023-12-01
    Get full text
    Article
    Save to List
    Saved in:
  12. 12
    Antibody Fab‐Fc properties outperform titer in predictive models of SIV vaccine‐induced protection

    Antibody Fab‐Fc properties outperform titer in predictive models of SIV vaccine‐induced protection by Srivamshi Pittala, Kenneth Bagley, Jennifer A Schwartz, Eric P Brown, Joshua A Weiner, Ilia J Prado, Wenlei Zhang, Rong Xu, Ayuko Ota‐Setlik, Ranajit Pal, Xiaoying Shen, Charles Beck, Guido Ferrari, George K Lewis, Celia C LaBranche, David C Montefiori, Georgia D Tomaras, Galit Alter, Mario Roederer, Timothy R Fouts, Margaret E Ackerman, Chris Bailey‐Kellogg

    Published 2019-05-01
    Get full text
    Article
    Save to List
    Saved in:
  13. 13
    Selection of an HLA-C*03:04-Restricted HIV-1 p24 Gag Sequence Variant Is Associated with Viral Escape from KIR2DL3+ Natural Killer Cells: Data from an Observational Cohort in South Africa.

    Selection of an HLA-C*03:04-Restricted HIV-1 p24 Gag Sequence Variant Is Associated with Viral Escape from KIR2DL3+ Natural Killer Cells: Data from an Observational Cohort in South... by Angelique Hölzemer, Christina F Thobakgale, Camilo A Jimenez Cruz, Wilfredo F Garcia-Beltran, Jonathan M Carlson, Nienke H van Teijlingen, Jaclyn K Mann, Manjeetha Jaggernath, Seung-gu Kang, Christian Körner, Amy W Chung, Jamie L Schafer, David T Evans, Galit Alter, Bruce D Walker, Philip J Goulder, Mary Carrington, Pia Hartmann, Thomas Pertel, Ruhong Zhou, Thumbi Ndung'u, Marcus Altfeld

    Published 2015-11-01
    Get full text
    Article
    Save to List
    Saved in:
  14. 14
    Copy number variation of KIR genes influences HIV-1 control.

    Copy number variation of KIR genes influences HIV-1 control. by Kimberly Pelak, Anna C Need, Jacques Fellay, Kevin V Shianna, Sheng Feng, Thomas J Urban, Dongliang Ge, Andrea De Luca, Javier Martinez-Picado, Steven M Wolinsky, Jeremy J Martinson, Beth D Jamieson, Jay H Bream, Maureen P Martin, Persephone Borrow, Norman L Letvin, Andrew J McMichael, Barton F Haynes, Amalio Telenti, Mary Carrington, David B Goldstein, Galit Alter, NIAID Center for HIV/AIDS Vaccine Immunology

    Published 2011-11-01
    Get full text
    Article
    Save to List
    Saved in:
  15. 15
    Immune correlates of early clearance of Mycobacterium tuberculosis among tuberculosis household contacts in Indonesia

    Immune correlates of early clearance of Mycobacterium tuberculosis among tuberculosis household contacts in Indonesia by Todia P. Setiabudiawan, Lika Apriani, Ayesha J. Verrall, Fitria Utami, Marion Schneider, Agnes R. Indrati, Pauline P. Halim, Paulina Kaplonek, Hadar Malca, Jessica Shih-Lu Lee, Simone J. C. F. M. Moorlag, L. Charlotte J. de Bree, Vera P. Mourits, Leo A. B. Joosten, Mihai G. Netea, Bachti Alisjahbana, Ryan P. McNamara, Galit Alter, Arjan van Laarhoven, James E. Ussher, Katrina Sharples, Valerie A. C. M. Koeken, Philip C. Hill, Reinout van Crevel

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  16. 16
    Schistosoma mansoni infection alters the host pre-vaccination environment resulting in blunted Hepatitis B vaccination immune responses.

    Schistosoma mansoni infection alters the host pre-vaccination environment resulting in blunted Hepatitis B vaccination immune responses. by Roshell Muir, Talibah Metcalf, Slim Fourati, Yannic Bartsch, Jacqueline Kyosiimire-Lugemwa, Glenda Canderan, Galit Alter, Enoch Muyanja, Brenda Okech, Teddy Namatovu, Irene Namara, Annemarie Namuniina, Ali Ssetaala, Juliet Mpendo, Annet Nanvubya, Paul Kato Kitandwe, Bernard S Bagaya, Noah Kiwanuka, Jacent Nassuna, Victoria Menya Biribawa, Alison M Elliott, Claudia J de Dood, William Senyonga, Priscilla Balungi, Pontiano Kaleebu, Yunia Mayanja, Matthew Odongo, Jennifer Connors, Pat Fast, Matt A Price, Paul L A M Corstjens, Govert J van Dam, Anatoli Kamali, Rafick Pierre Sekaly, Elias K Haddad

    Published 2023-07-01
    Get full text
    Article
    Save to List
    Saved in:
  17. 17
    Preclinical development of a replication-competent vesicular stomatitis virus-based Lassa virus vaccine candidate advanced into human clinical trialsResearch in context

    Preclinical development of a replication-competent vesicular stomatitis virus-based Lassa virus vaccine candidate advanced into human clinical trialsResearch in context by Christopher L. Cooper, Gavin Morrow, Maoli Yuan, Thomas S. Postler, Maxwell L. Neal, Robert W. Cross, Courtney Woolsey, Krystle N. Agans, Viktoriya Borisevich, Ryan P. McNamara, Caroline Atyeo, Vicky Roy, Daritza Germosen, Fuxiang Hou, Shui L. Li, Lucia Reiserova, Yesle Choi, Aaron Wilson, Denise Wagner, Olivia Wallace-Selman, Alexei Carpov, Fuqiang Geng, Deborah J. Frederick, Joanne DeStefano, Anne M. Ercolini, Adrian S. Enriquez, Kathryn M. Hastie, Suzane Ramos da Silva, Eddy Sayeed, John W. Coleman, Andrew Kilianski, Galit Alter, Erica Ollmann Saphire, John D. Aitchison, Thomas W. Geisbert, Swati B. Gupta, Mark B. Feinberg, Christopher L. Parks

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: